Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
503.6 INR | -1.82% | -3.43% | +2.93% |
18/06 | Aarti Drugs Reports Fire Incident at Tarapur, India Unit | MT |
06/05 | Transcript : Aarti Drugs Limited, Q4 2024 Earnings Call, May 06, 2024 |
Sales 2024 | 2.53TCr 30Cr | Sales 2025 * | 2.76TCr 33Cr | Capitalization | 4.63TCr 56Cr |
---|---|---|---|---|---|
Net income 2024 | 171.4Cr 2.06Cr | Net income 2025 * | 237.5Cr 2.85Cr | EV / Sales 2024 | 1.58 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.68 x |
P/E ratio 2024 |
23.4
x | P/E ratio 2025 * |
20
x | Employees | 1,003 |
Yield 2024 * |
0.92% | Yield 2025 * |
1.25% | Free-Float | 38.06% |
Latest transcript on Aarti Drugs Limited
1 day | -1.82% | ||
1 week | -3.43% | ||
Current month | +5.59% | ||
1 month | +4.31% | ||
3 months | +14.24% | ||
6 months | +1.18% | ||
Current year | +2.93% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 76 | 05/85/05 | |
Adhish P. Patil
DFI | Director of Finance/CFO | 41 | 06/12/06 |
Rushikesh Deole
CMP | Compliance Officer | - | 23/19/23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 76 | 05/85/05 | |
Director/Board Member | 61 | 02/87/02 | |
Director/Board Member | 60 | 15/95/15 |
Date | Price | Change | Volume |
---|---|---|---|
27/24/27 | 503.6 | -1.82% | 90 019 |
26/24/26 | 512.9 | -0.76% | 64,767 |
25/24/25 | 516.8 | +0.24% | 119,905 |
24/24/24 | 515.6 | +1.17% | 107,098 |
21/24/21 | 509.6 | -2.26% | 217,478 |
Delayed Quote NSE India S.E., June 27, 2024 at 05:13 pm IST
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+55.11% | 81TCr | |
+43.82% | 64TCr | |
-6.42% | 35TCr | |
+19.36% | 33TCr | |
+9.75% | 30TCr | |
+17.31% | 25TCr | |
+2.49% | 22TCr | |
+12.81% | 22TCr | |
+9.06% | 17TCr |
- Stock Market
- Equities
- AARTIDRUGS Stock
- AARTIDRUGS Stock